GB2431874A - Lubricant - Google Patents
Lubricant Download PDFInfo
- Publication number
- GB2431874A GB2431874A GB0522423A GB0522423A GB2431874A GB 2431874 A GB2431874 A GB 2431874A GB 0522423 A GB0522423 A GB 0522423A GB 0522423 A GB0522423 A GB 0522423A GB 2431874 A GB2431874 A GB 2431874A
- Authority
- GB
- United Kingdom
- Prior art keywords
- lubricant
- lubricant according
- glyceryl
- polmer
- cps
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000314 lubricant Substances 0.000 title claims abstract description 201
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims abstract description 57
- -1 alkylene glycol Chemical compound 0.000 claims abstract description 45
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims abstract description 41
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims abstract description 41
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 18
- 150000001875 compounds Chemical class 0.000 claims abstract description 17
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 16
- 206010047791 Vulvovaginal dryness Diseases 0.000 claims abstract description 15
- 229930003799 tocopherol Natural products 0.000 claims abstract description 14
- 239000011732 tocopherol Substances 0.000 claims abstract description 14
- 241001116389 Aloe Species 0.000 claims abstract description 9
- 229960001295 tocopherol Drugs 0.000 claims abstract description 9
- 235000010384 tocopherol Nutrition 0.000 claims abstract description 9
- 150000003612 tocotrienol derivatives Chemical class 0.000 claims abstract description 9
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 9
- 210000001215 vagina Anatomy 0.000 claims description 40
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 22
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 20
- 235000019438 castor oil Nutrition 0.000 claims description 16
- 239000004359 castor oil Substances 0.000 claims description 16
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 16
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 11
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 11
- 229960002216 methylparaben Drugs 0.000 claims description 11
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 10
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 10
- 229960003415 propylparaben Drugs 0.000 claims description 10
- 238000011282 treatment Methods 0.000 claims description 10
- 229920001577 copolymer Polymers 0.000 claims description 9
- 239000000230 xanthan gum Substances 0.000 claims description 9
- 229920001285 xanthan gum Polymers 0.000 claims description 9
- 235000010493 xanthan gum Nutrition 0.000 claims description 9
- 229940082509 xanthan gum Drugs 0.000 claims description 9
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 8
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 8
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 8
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 8
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 8
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 8
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 8
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 8
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 8
- 229920000609 methyl cellulose Polymers 0.000 claims description 8
- 239000001923 methylcellulose Substances 0.000 claims description 8
- 235000010981 methylcellulose Nutrition 0.000 claims description 8
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 8
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 8
- 229940068977 polysorbate 20 Drugs 0.000 claims description 8
- 235000010241 potassium sorbate Nutrition 0.000 claims description 8
- 239000004302 potassium sorbate Substances 0.000 claims description 8
- 229940069338 potassium sorbate Drugs 0.000 claims description 8
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 8
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 8
- 229940061629 trideceth-9 Drugs 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 208000024891 symptom Diseases 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims 4
- 229960002900 methylcellulose Drugs 0.000 claims 4
- 235000002961 Aloe barbadensis Nutrition 0.000 abstract description 7
- 244000186892 Aloe vera Species 0.000 abstract description 7
- 229920000193 polymethacrylate Polymers 0.000 abstract description 4
- 229920000642 polymer Polymers 0.000 abstract 1
- 238000005461 lubrication Methods 0.000 description 17
- 230000001568 sexual effect Effects 0.000 description 10
- 239000000203 mixture Substances 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 235000019149 tocopherols Nutrition 0.000 description 5
- 235000019165 vitamin E Nutrition 0.000 description 5
- 239000011709 vitamin E Substances 0.000 description 5
- 229940046009 vitamin E Drugs 0.000 description 5
- 210000003905 vulva Anatomy 0.000 description 5
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 239000000262 estrogen Substances 0.000 description 4
- 239000003349 gelling agent Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 230000037007 arousal Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 1
- 206010030247 Oestrogen deficiency Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010047786 Vulvovaginal discomfort Diseases 0.000 description 1
- 206010069055 Vulvovaginal pain Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
Abstract
A lubricant comprising 20-50% water, 30-50% alkylene glycol, such as propylene glycol, and 7-21% glyceryl polymer, such as glyceryl polymethacrylate. The lubricant may comprise an aloe compound such as aloe vera. The lubricant may comprise one or more tocopherol and/or tocotrienol compounds. The lubricant is for alleviating vaginal dryness. Also disclosed is a delivery device for administering the lubricant and the delivery device is preferably disposable.
Description
<p>2 2431874 Lubricant The present invention relates to a lubricant, a
delivery device for a lubricant, a lubricant for treating vaginal dryness, at all ages and especially in menopausal and post menopausal women, the use of a lubricant for the manufacture of a medicament for the treatment of vaginal dryness and a method for the treatment of symptoms of vaginal dryness.</p>
<p>Vaginal dryness is common in women of all ages but is particularly prevalent in menopausal and postmenopausal women.</p>
<p>The main causes include, impaired sexual arousal, oestrogen deficiency, disease, trauma, pelvic radiotherapy and the effect of some drugs.</p>
<p>Vaginal dryness can present either as a basal dryness which can give rise to symptoms such as vulval soreness and irritation, or as a dryness during sexual arousal, precluding comfortable penile vaginal penetration during intercourse.</p>
<p>At present a treatment for vaginal dryness in postmenopausal women, when oestrogen levels are low, is oestrogen replacement therapy. Although oestrogen therapy is generally believed to be safe in the short term, some women have reservations about embarking on such treatments and so lubricants are often used during sexual activity as an alternative. Even for those women who are happy to rely on hormone treatment, it can take up to three months before any beneficial effects are noted. In the meantime these women are advised to use a lubricant to treat their vaginal dryness. Furthermore, when oestrogen replacement is discontinued, vaginal dryness can recur causing painful or uncomfortable sexual activity which can be relieved by the use of a lubricant.</p>
<p>The present invention provides a lubricant, which can be applied to the vagina to reduce dryness. The lubricant is most preferably for use prior to or during sexual activity.</p>
<p>According to a first aspect of the present invention there is provided a lubricant comprising from 20 to 50% water, from 30 to 50% of an alkylene glycol and from 7 to 21 % of a glyceryl polmer.</p>
<p>This lubricant can be advantageous over currently available lubricants because the relative amounts of the constituent ingredients result in a lubricant, which has an improved consistency over conventional lubricants. In particular the consistency may allow the lubricant to remain at the locality at which it is placed for a longer period of time than seen with conventional lubricants. In particular the lubricant when applied to the inside of the vagina, may stay inside the vagina for a longer period of time than seen with conventional lubricants. This advantageously allows the lubricant to be applied in privacy well before intercourse. Any leakage of the lubricant may provide lubrication of the vulva during foreplay thereby relieving discomfort due to dryness during clitoral stimulation by any means.</p>
<p>Preferably the lubricant comprises from 25 to 45% water, more preferably from 30 to 40% water, and most preferably 33.87% water.</p>
<p>Ideally the lubricant comprises from 32 to 48% of an alkylene glycol, more preferably from 34 to 46% of an alkylene glycol, more preferably 36 to 44% of an alkylene glycol, more preferably 38 to 42% of an alkylene glycol, and most preferably comprises 41.83% of an alkylene glycol. Ideally the alkylene glycol is propylene glycol.</p>
<p>In a preferred embodiment the lubricant comprises from 7 to 21 % of a glyceryl polmer, in a more preferred embodiment the lubricant comprises from 9 to 19% of a glyceryl polmer, in a more preferred embodiment the lubricant comprises from 10 to 17% of a glyceryl polmer, in a more preferred embodiment the lubricant comprises from 11 to 15% of a glyceryl polmer, in a more preferred embodiment the lubricant comprises from 12 to 14% of a glyceryl polmer, in a most preferred embodiment the lubricant comprises 13.65% of a glyceryl polmer. Ideally the glyceryl polmer is glyceryl polmethacrylate.</p>
<p>The lubricant advantageously has a viscosity which allows it to be placed inside the vagina providing internal lubrication.</p>
<p>This advantageously allows the lubricant to be applied in privacy well before intercourse. Any leakage of the lubricant may provide lubrication of the vulva during foreplay thereby relieving discomfort due to dryness during clitoral stimulation by any means.</p>
<p>Ideally at least some of the lubricant when applied to the vagina will remain inside the vagina for up to 36 hours.</p>
<p>However more preferably the viscosity is such that at least some of the lubricant will remain in place inside the vagina for up to 24 hours, more preferably for up to 12 hours and most preferably for up to 6 hours. This effect can be achieved without the inclusion of adhesives in the lubricant. Most preferably the amount of lubricant, which remains inside the vagina during use, is enough to provide adequate lubrication for sexual intercourse. Preferably from 20% to 100% remains inside the vagina, more preterably from 40% to 100%, more preferably from 60% to 95%, and most preferably from 80% to 90%.</p>
<p>The lubricant most preferably has a viscosity of from 12,000 cps to 17,000 cps, more preferably, from 13,000 cps to 16,000 cps, more preferably from 14,000 cps to 15,000 cps and most preferably 14,360 cps. Ideally the lubricant's viscosity is measured at 20 C. Preferably the viscosity is stable. Most preferably the viscosity does not vary more than 2.5% over 6 weeks but more preferably over 12 weeks.</p>
<p>The lubricant also preferably includes one or more tocopherol and/or tocotrienol compounds (vitamin E), most preferably a mix of tocopherols. Ideally the lubricant may comprise an aloe compound for example aloe vera. The addition of either or both of these substances can result in a lubricant, which has properties that encourage cell regeneration.</p>
<p>The lubricant may also comprise one or more of the following compounds: A preservative (for example methylparaben, propylparaben or potassium sorbate), a compound to solubilise any oily/ insoluable components (for example, PEG-40 hydrogenated castor oil, PEG-40 hydrogenated castor oil, polysorbate 20, PPG-26-buthth-26 and trideceth-9), a gelling agent (for example, xanthan gum, or a cellulose for example, methylcellulose, hydroxyethylcellulose, hyroxypropylmethylcellulose, hydroxypropylcellulose and sodium carboxymethylcellulose) and/or a PVM/MA copolymer.</p>
<p>A second aspect of the present invention provides a lubricant comprising one or more tocopherol and/or tocotrienol compounds (for example a commercially available vitamin E compound), most preferably a mix of tocopherols. The addition of vitamin E to a lubricant may provide a product which encourages cell regeneration in addition to its lubrication qualities.</p>
<p>Preferred features of this second aspect of the invention may be as described above in connection with the first aspect.</p>
<p>In particular the lubricant may further comprise one or more of water, an alkylene glycol and a glyceryl polmer. Preferably the lubricant comprises water, an alkylene glycol and a glyceryl polmer. Ideally the lubricant comprises from 20 to 50% water, from 30 to 50% of an alkylene glycol and from 7 to 21 % of a glyceryl polmer.</p>
<p>Preferably the lubricant comprises from 25 to 45% water, more preferably from 30 to 40% water and most preferably 33.87% water.</p>
<p>Ideally the lubricant comprises from 32 to 48% of an alkylene glycol, more preferably from 34 to 46% of an alkylene glycol, more preferably 36 to 44% of an alkylene glycol, more preferably 38 to 42% of an alkylene glycol, and most preferably comprises 41.83% of an alkylene glycol. Ideally the alkylene glycol is propylene glycol.</p>
<p>In a preferred embodiment the lubricant comprises from 7 to 21 % of a glyceryl polmer, in a more preferred embodiment the lubricant comprises from 9 to 19% of a glyceryl polmer, in a more preferred embodiment the lubricant comprises from 10 to 17% of a glyceryl polmer, in a more preferred embodiment the lubricant comprises from 11 to 15% of a glyceryl polmer, in a more preferred embodiment the lubricant comprises from 12 to 14% of a glyceryl polmer, in a most preferred embodiment the lubricant comprises 13.65% of a glyceryl polmer. Ideally the glyceryl polmer is glyceryl polmethacrylate.</p>
<p>The lubricant advantageously has a viscosity which allows it to be placed inside the vagina providing internal lubrication.</p>
<p>This advantageously allows the lubricant to be applied in privacy well before intercourse. Any leakage of the lubricant may provide lubrication of the vulva during foreplay thereby relieving discomfort due to dryness during clitoral stimulation by any means. This effect may be achieved without the inclusion of adhesives in the lubricant.</p>
<p>Ideally at least some of the lubricant when applied to the vagina will remain inside the vagina for up to 36 hours.</p>
<p>However more preferably the viscosity is such that at least some of the lubricant will remain in place inside the vagina for up to 24 hours, more preferably for up to 12 hours and most preferably for up to 6 hours. Most preferably the amount of lubricant, which remains inside the vagina during use, is enough to provide adequate lubrication for sexual intercourse.</p>
<p>Preferably from 20% to 100% remains inside the vagina, more preferably from 40% to 100%, more preferably from 60% to 95%, and most preferably from 80% to 90%.</p>
<p>The lubricant most preferably has a viscosity of from 12,000 cps to 17,000 cps, more preferably, from 13,000 cps to 16,000 cps, more preferably from 14,000 cps to 15,000 cps and most preferably 14,360 cps. Ideally the lubricant's viscosity is measured at 20 C. Preferably the viscosity is stable. Most preferably the viscosity does not vary more than 2.5% over 6 weeks but more preferably over 12 weeks.</p>
<p>Ideally the lubricant may also further comprise an aloe compound for example aloe vera.</p>
<p>The lubricant may also comprise one or more of the following compounds: A preservative (for example methylparaben, propylparaben or potassium sorbate), a compound to solubilise any oily/ insoluable components (for example, PEG-40 hydrogenated castor oil, PEG-40 hydrogenated castor oil, polysorbate 20, PPG-26-buthth-26 and trideceth-9), a gelling agent (for example, xanthan gum, or a cellulose for example, methylcellulose, hydroxyethylcellulose, hyroxypropylmethylcellulose, hydroxypropylcellulose and sodium carboxymethylcellulose) and/or a PVM/MA copolymer.</p>
<p>A third aspect of the present invention proves a lubricant comprising an aloe compound for example aloe vera. The addition of aloe vera to a lubricant can provide a product which may encourage cell regeneration in addition to its lubrication qualities.</p>
<p>Preferred features of this third aspect of the invention may be as described above in connection with the first and second aspects.</p>
<p>In particular the lubricant may further comprise one or more of water, an alkylene glycol and a glyceryl polmer. Ideally the lubricant comprises water, an alkylene glycol and a glyceryl polmer. Ideally the lubricant comprises from 20 to 50% water, from 30 to 50% of an alkylene glycol and from 7 to 21 % of a glyceryl polmer.</p>
<p>Preferably the lubricant comprises from 25 to 45% water, more preferably from 30 to 40% water and most preferably 33.87% water.</p>
<p>Ideally the lubricant comprises from 32 to 48% of an alkylene glycol, more preferably from 34 to 46% of an alkylene glycol, more preferably 36 to 44% of an alkylene glycol, more preferably 38 to 42% of an alkylene glycol, and most preferably comprises 41.83% of an alkylene glycol. Ideally the alkylene glycol is propylene glycol.</p>
<p>In a preferred embodiment the lubricant comprises from 7 to 21 % of a glyceryl polmer, in a more preferred embodiment the lubricant comprises from 9 to 19% of a glyceryl polmer, in a more preferred embodiment the lubricant comprises from 10 to 17% of a glyceryl polmer, in a more preferred embodiment the lubricant comprises from 11 to 15% of a glyceryl polmer, in a more preferred embodiment the lubricant comprises from 12 to 14% of a glyceryl polmer, in a most preferred embodiment the lubricant comprises 13.65% of a glyceryl polmer. Ideally the glyceryl polmer is glyceryl polmethacrylate.</p>
<p>The lubricant advantageously has a viscosity which allows it to be placed inside the vagina providing internal lubrication.</p>
<p>This advantageously allows the lubricant to be applied in privacy well before intercourse. Any leakage of the lubricant may provide lubrication of the vulva during foreplay thereby relieving discomfort due to dryness during clitoral stimulation by any means. This effect can be achieved without the inclusion of adhesives in the lubricant.</p>
<p>Ideally at least some of the lubricant when applied to the vagina will remain inside the vagina for up to 36 hours.</p>
<p>However more preferably the viscosity is such that at least some of the lubricant will remain in place inside the vagina for up to 24 hours, more preferably for up to 12 hours and most preferably for up to 6 hours. Most preferably the amount of lubricant, which remains inside the vagina during use, is enough to provide adequate lubrication for sexual intercourse.</p>
<p>Preferably from 20% to 100% remains inside the vagina, more preferably from 40% to 100%, more preferably from 60% to 95%, and most preferably from 80% to 90%.</p>
<p>The lubricant most preferably has a viscosity of from 12,000 cps to 17,000 cps, more preferably, from 13,000 cps to 16,000 cps, more preferably from 14,000 cps to 15,000 cps and most preferably 14,360 cps. Ideally the lubricant's viscosity is measured at 20 C. Preferably the viscosity is stable. Most preferably the viscosity does not vary more than 2.5% over 6 weeks but more preferably over 12 weeks.</p>
<p>Ideally the lubricant may also further comprise one or more tocopherol and/or tocotrienol compounds (for example commercially available vitamin E), most preferably a mix of tocopherols.</p>
<p>The lubricant may also comprise one or more of the following compounds: A preservative (for example methylparaben, propylparaben or potassium sorbate), a compound to solubilise any oily/ insoluable components (for example, PEG-40 hydrogenated castor oil, PEG-40 hydrogenated castor oil, polysorbate 20, PPG-26-buthth-26 and trideceth-9), a gelling agent (for example, xanthan gum, or a cellulose for example, methylcellulose, hydroxyethylcellulose, hyroxypropylmethylcellulose, hydroxypropylcellulose and sodium carboxymethylcellulose) and/or a PVM/MA copolymer.</p>
<p>A fourth aspect of the present invention proves a lubricant having a viscosity of from 12,000 cps to 17,000 cps. This viscosity advantageously may allow the lubricant to be placed inside the vagina providing internal lubrication. This advantageously allows the lubricant to be applied in privacy well before intercourse. Any leakage of the lubricant may provide lubrication of the vulva during foreplay thereby relieving discomfort due to dryness during clitoral stimulation by any means. This effect may be achieved without the inclusion of adhesives in the lubricant.</p>
<p>Ideally at least some of the lubricant when applied to the vagina will remain inside the vagina for up to 36 hours.</p>
<p>However more preferably the viscosity is such that at least some of the lubricant will remain in place inside the vagina for up to 24 hours, more preferably for up to 12 hours and most preferably for up to 6 hours. Most preferably the amount of lubricant, which remains inside the vagina during use, is enough to provide adequate lubrication for sexual intercourse.</p>
<p>Preferably from 20% to 100% remains inside the vagina, more preferably from 40% to 100%, more preferably from 60% to 95%, and most preferably from 80% to 90%.</p>
<p>Preferred features of this fourth aspect of the invention may be as described above in connection with the first, second and third aspects.</p>
<p>In a preferred embodiment the lubricant has a viscosity of from 13,000 cps to 16,000 cps, more preferably from 14,000 cps to 15,000 cps and most preferably 14,360 cps. Ideally the lubricant's viscosity is measured at 20 C. Preferably the viscosity is stable. Most preferably the viscosity does not vary more than 2.5% over 6 weeks but more preferably over 12 weeks.</p>
<p>To help achieve a desired consistency the lubricant preferably comprises from 20 to 50% water, from 30 to 50% of an alkylene glycol and from 7 to 21 % of a glyceryl polmer.</p>
<p>In a preferred embodiment the lubricant comprises from 25 to 45% water, more preferably from 30 to 40% water, and most preferably 33.87% water.</p>
<p>Ideally the lubricant comprises from 32 to 48% of an alkylene glycol, more preferably from 34 to 46% of an alkylene glycol, more preferably 36 to 44% of an alkylene glycol, more preferably 38 to 42% of an alkylene glycol, and most preferably comprises 41.83% of an alkylene glycol. Ideally the alkylene glycol is propylene glycol.</p>
<p>In a preferred embodiment the lubricant comprises from 7 to 21 % of a glyceryl polmer, in a more preferred embodiment the lubricant comprises from 9 to 19% of a glyceryl polmer, in a more preferred embodiment the lubricant comprises from 10 to 17% of a glyceryl polmer, in a more preferred embodiment the lubricant comprises from 11 to 15% of a glyceryl polmer, in a more preferred embodiment the lubricant comprises from 12 to 14% of a glyceryl polmer, in a most preferred embodiment the lubricant comprises 13.65% of a glyceryl polmer. Ideally the glyceryl polmer is glyceryl polmethacrylate.</p>
<p>Ideally the lubricant may also further comprise one or more tocopherol and/or tocotrienol compounds (vitamin E), most preferably a mix of tocopherols. The lubricant may comprise an aloe compound for example aloe vera.</p>
<p>The lubricant may also comprise one or more of the following compounds: A preservative (for example methylparaben, propylparaben or potassium sorbate), a compound to solubilise any oily/ insoluable components (for example, PEG-40 hydrogenated castor oil, PEG-40 hydrogenated castor oil, polysorbate 20, PPG-26-buthth-26 and trideceth-9), a gelling agent (for example, xanthan gum, or a cellulose for example, methylcellulose, hydroxyethylcellulose, hyroxypropylmethylcellulose, hydroxypropylcellulose and sodium carboxymethylcellulose) and/or a PVM/MA copolymer.</p>
<p>Presently available lubricants are normally contained within a tube. When the lubricant is needed a small amount is squeezed from the tube onto a user's finger or fingers. The lubricant is then manually applied to the external genital area by the user.</p>
<p>Thus lubricant is not typically applied to the inside of the vagina where it is most needed to aid penetration.</p>
<p>Therefore a fifth aspect of the present invention provides a delivery device for a lubricant comprising a squeezable container having an elongate dispensing nozzle, wherein the dispensing nozzle is from 20mm to 65mm in length.</p>
<p>This dispensing device is advantageous as it can allow a lubricant contained within it to be dispensed directly into the vagina where it is most needed. The dispensing nozzle is preferably from 30mm to 65mm in length, more preferably from 40mm to 60mm, and most preferably 55mm in length. Ideally the delivery device contains a lubricant. Preferably the lubricant is as described in connection with the first, second, third and/or fourth aspects of this invention.</p>
<p>In a preferred embodiment the container is opaque, transparent or translucent such that when it is charged with a lubricant, the volume of lubricant held within it can be seen. This is advantageous, as it can allow a user to control the amount of lubricant dispensed. Providing a volume indicator on the container can further enhance this advantage.</p>
<p>The container and/or the dispensing nozzle is preferably made from a plastics material, for example polyethylene, polyvinyl chloride, ABS. polypropylene, polycarbonate, nylon, acrylic or a composite of 2 or more plastics.</p>
<p>In a preferred embodiment the delivery device is sized for containing a single dose of lubricant and is most preferably disposable. Ideally the delivery device contains from 2m1 to 2Oml of lubricant, more preferably of from 3ml to 15m1 of lubricant, more preferably of from 4m1 to lOml of lubricant and most preferably 5m1 of lubricant. This volume has been found to provide adequate lubrication for a single use.</p>
<p>A sixth aspect of the present invention provides a delivery device for a lubricant comprising a squeezable container having an elongate dispensing nozzle, wherein the container is at least partially opaque, transparent or translucent, for example to allow a user to gauge how much lubricant is left inside the delivery device. Preferably the delivery device is as described in connection with the fifth aspect of this invention.</p>
<p>Ideally the delivery device further contains a lubricant.</p>
<p>Preferably the lubricant is as described in connection with the first, second, third and/or fourth aspects of this invention.</p>
<p>As stated above the opaque, transparent or translucent nature of the container means that when it is charged with a lubricant, the volume of the lubricant can be seen. This is advantageous, as it can allow a user to control the amount of lubricant dispensed. Providing a volume indicator on the container, indicating volume can further enhance this advantage In a preferred embodiment the dispensing nozzle is from 20mm to 65mm in length, more preferably from 30mm to 65mm in length, more preferably from 40mm to 60mm, and most preferably 55mm in length.</p>
<p>In a preferred embodiment the delivery device is sized for containing a single dose of lubricant and is most preferably disposable. Ideally the delivery device contains from 2m1 to 2Oml of lubricant, more preferably of from 3m1 to 15m1 of lubricant, more preferably of from 4m1 to lOml of lubricant and most preferably Sml of lubricant. This volume has been found to provide adequate lubrication.</p>
<p>In a seventh aspect of the present invention there is provided a lubricant for use in treating vaginal dryness.</p>
<p>In an eighth aspect of the present invention there is provided the use of a vaginal lubricant for the manufacture of a medicament for the treatment of vaginal dryness. The medicament preferably being presented as a dosage form in a delivery device as defined above.</p>
<p>In a ninth aspect of the present invention there is provided a method for the treatment of symptoms of vaginal dryness, comprising introducing into a vagina a lubricant as described above in relation to the first, second, third and/or fourth aspects of the present invention. Most preferably the lubricant is introduced into the vagina using a delivery device as described in accordance with the fifth and/or sixth aspects of the present invention. Preferably the lubricant is introduced into the top third of the vagina, and most preferably at the top of the vagina. The lubricant may be introduced into the vagina before intercourse, preferably before or during foreplay.</p>
<p>Ideally the lubricant may be introduced into the vagina up to 6 hours before intercourse. However the lubricant is most preferably applied up to an hour prior to sexual activity. This advantageously may allow a woman use the lubricant in privacy, and in particular without her partners knowledge. Alternatively it may be used as part of foreplay together.</p>
<p>Other features of the present invention will become apparent from the following examples. Generally speaking the invention extends to any novel one, or novel combination of the features disclosed in this specification (including any accompanying claims and drawing) . Moreover unless stated otherwise, any feature disclosed herein may be replaced by an alternative feature serving the same or a similar purpose.</p>
<p>In order that the invention may be more fully understood, a preferred embodiment of lubricant and delivery device in accordance therewith will now be described by way of example only and with reference to the accompanying illustrative figure which shows a plan view of the dispensing device in accordance with the present invention.</p>
<p>A lubricant was formed by mixing 0.15% w/w of methylparaben, 5% w/w of PEG-40 hydrogenated caster oil and 0.25% w/w of mixed tocopherols 95 in a first vessel. These three ingredients were stirred and warmed slightly. 41.5% w/w of propylene glycol was then added to the first vessel, followed by 5% w/w of aloe vera 10-1 and 18% w/w of a first commercially available lubricant containing water, propylene glycol, glyceryl polymethacrylate, PCM/MA copolymer, methylparaben and propylparaben. In a second vessel 0.1% w/w of Xanthan gum and 15% w/w of water were added and gently stirred to hydrate until the mixture was smooth and uniform. Once fully hydrated the contents of the second vessel were added to the main vessel and mixed until uniform. 15% w/w of a second commercially available lubricant containing water, propylene glycol, glyceryl polymethacrylate, methylparaben and propylparaben was then added to the main vessel and stirred gently until the resulting mixture was smooth and clear. The final lubricant contained 33.87% water, 41.83% propylene glycol and 13.65% of glyceryl polymethacrylate.</p>
<p>The lubricant is most preferably placed inside a delivery device as shown in the Figure. As can be seen from the Figure the delivery device, which is indicated generally at 1 comprises a squeezable container 2 having an elongate dispensing nozzle 4.</p>
<p>The dispensing nozzle 4 is preferably 4.5cm long.</p>
<p>The container 2 and dispensing nozzle 4 are preferably made from a plastics material. The container 2 may be opaque but is most preferably transparent or translucent such that the volume of lubricant 6 held within it can be seen. The dispensing nozzle 4 may be opaque but is preferably also transparent or translucent.</p>
<p>Ideally the container 2 also has a volume indicator 8. In a preferred embodiment a tip 10 of the dispensing nozzle 4 has a breakable seal 12.</p>
<p>In use the breakable seal 12 is removed and the dispensing nozzle 4 is inserted into the vagina of a user. The tip 10 of the nozzle 4 is most preferably positioned in the top third of the vagina. Once the tip 10 of the nozzle 4 is in position, the container 2 is squeezed to dispense the lubricant 6 into the vagina.</p>
Claims (1)
- <p>Claims 1. A lubricant comprising from 20 to 50% water, 30 to 50% of analkylene glycol and 7 to 21 % of a glyceryl polmer.</p><p>2. A lubricant according to claim 1 wherein the alkylene glycol is propylene glycol.</p><p>3. A lubricant according to claim 1 or 2 wherein the glyceryl polmer is glyceryl polmethacrylate.</p><p>4. A lubricant according to any preceding claim further comprising one or more tocopherol and/or tocotrienol compounds.</p><p>5. A lubricant according to any preceding claim further comprising an aloe compound.</p><p>6. A lubricant according to any preceding claim having a viscosity of from 12,000 cps to 17,000 cps.</p><p>7. A lubricant according to any preceding claim further comprising one or more of methylparaben, propylparaben, potassium sorbate, PEG-40 hydrogenated castor oil, PEG-40 hydrogenated castor oil, polysorbate 20, FPG-26-buthth-26, trideceth-9, xanthan Gum, methylcellulose, hydroxyethylcellulose, hyroxypropylmethylcellulose, hydroxypropylcellulose, sodium carboxymethylcellulose and/or a PVM/MA copolymer.</p><p>8. A lubricant comprising one or more tocopherol and/or tocotrienol compounds.</p><p>9. A lubricant according to claim 8 further comprising one or more of water, an alkylene glycol and a glyceryl polmer.</p><p>10. A lubricant according to claim 9 wherein the alkylene glycol is propylene glycol.</p><p>11. A lubricant according to claim 9 or 10 wherein the glyceryl polmer is glyceryl polmetacrylate.</p><p>12. A lubricant according to any of claims 8 to 11 further comprising an aloe compound.</p><p>13. A lubricant according to any of claims 8 to 12 having a viscosity of from 12,000 cps to 17,000 cps.</p><p>14. A lubricant according to any of claims 8 to 13 further comprising one or more of methylparaben, propylparaben, potassium sorbate, PEG-40 hydrogenated castor oil, PEG-40 hydrogenated castor oil, polysorbate 20, PPG-26-buthth-26, trideceth-9, xanthan Gum, methylcellulose, hydroxyethylcellulose, hyroxypropylmethylcellulose, hydroxypropylcellulose, sodium carboxymethylcellulose and/or a PVM/MA copolymer.</p><p>15. A lubricant comprising an aloe compound.</p><p>16. A lubricant according to claim 15 further comprising one or more of water, an alkylene glycol and a glyceryl polmer.</p><p>17. A lubricant according to claim 16 wherein the alkylene glycol is propylene glycol.</p><p>18. A lubricant according to claim 16 or 17 wherein glyceryl polmer is glyceryl polmetacrylate.</p><p>19. A lubricant according to any of claims 15 to 18 further comprising one or more tocopherol and/or tocotrienol compounds.</p><p>20. A lubricant according to any of claims 15 to 19 having a viscosity of from 12,000 cps to 17,000 cps.</p><p>21. A lubricant according to any of claims 15 to 20 further comprising one or more of methylparaben, propylparaben, potassium sorbate, PEG--40 hydrogenated castor oil, PEG-40 hydrogenated castor oil, polysorbate 20, PPG-26-buthth-26, trideceth-9, xanthan Gum, methylcellulose, hydroxyethylcellulose, hyroxypropylmethylcellulose, hydroxypropylcellulose, sodium carboxymethylcellulose and/or a PVM/MA copolymer.</p><p>22. A lubricant having a viscosity of from 12,000 cps to 17,000 cps.</p><p>23. A lubricant according to claim 22 comprising one or more of water, an alkylene glycol and a glyceryl polmer.</p><p>24. A lubricant according to claim 23 wherein the alkylene glycol is propylene glycol.</p><p>25. A lubricant according to claim 23 or 24 wherein the glyceryl polmer is glyceryl polmethacrylate.</p><p>26. A lubricant according to any of claims 23 to 25 further comprising one or more tocopherol and/or tocotrienol compounds.</p><p>27. A lubricant according to any of claims 23 to 26 further comprising an aloe compound.</p><p>28. A lubricant according to any of claims 23 to 27 further comprising one or more of methylparaben, propylparaben, potassium sorbate, PEG-40 hydrogenated castor oil, PEG-40 hydrogenated castor oil, polysorbate 20, PPG-26-buthth-26, trideceth-9, xanthan Gum, methylcellulose, hydroxyethylcellulose, hyroxypropylmethylcellulose, hydroxypropylcellulose, sodium carboxymethylcellulose and/or a PVM/MA copolymer.</p><p>29. A delivery device for a lubricant comprising a squeezable container having an elongate dispensing nozzle, wherein the dispensing nozzle is from 20mm to 65mm in length.</p><p>30. A delivery device for a lubricant according to claim 29 containing a lubricant according to any of claims 1 to 28.</p><p>31. A delivery device for a lubricant according to claim 29 or wherein the container is opaque, transparent or translucent.</p><p>32. A delivery device according to any of claims 29 to 31 wherein the container and/or dispensing nozzle further comprises a volume indicator.</p><p>33. A delivery device for a lubricant comprising a squeezable container having an elongate dispensing nozzle, wherein the container is opaque, transparent or translucent.</p><p>34. A delivery device according to claim 33 wherein the dispensing nozzle is from 20mm to 65mm in length.</p><p>35. A delivery device according to claim 34 containing a lubricant according to any of claims 1 to 28.</p><p>36. A delivery device according to any of claims 33 to 35 wherein the container and/or dispensing nozzle further comprises a volume indicator.</p><p>37. A lubricant according to any of claims 1 to 28 for use in the treatment of vaginal dryness.</p><p>38. Use of a lubricant according to any of claims 1 to 28 for the manufacture of a medicament for the treatment of vaginal dryness.</p><p>39. A method for the treatment of symptoms of vaginal dryness comprising introducing into a vagina a lubricant according to any of claims 1 to 28.</p><p>41. A method according to claim 40 wherein the lubricant is introduced into the vagina using a delivery device according to any of claims 28 to 36.</p>
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0522423A GB2431874A (en) | 2005-11-03 | 2005-11-03 | Lubricant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0522423A GB2431874A (en) | 2005-11-03 | 2005-11-03 | Lubricant |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0522423D0 GB0522423D0 (en) | 2005-12-14 |
GB2431874A true GB2431874A (en) | 2007-05-09 |
Family
ID=35516258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0522423A Withdrawn GB2431874A (en) | 2005-11-03 | 2005-11-03 | Lubricant |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2431874A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120263694A1 (en) * | 2009-04-01 | 2012-10-18 | Susan Mary Lennox | Intimate Lubrication Kit |
CN110709070A (en) * | 2017-03-31 | 2020-01-17 | Itf制药研究责任有限公司 | Lubricating oil formulation |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003028691A2 (en) * | 2001-09-27 | 2003-04-10 | Johnson & Johnson Consumer France S.A.S. | Stable compositions containing ethanolamine derivatives and glucosides |
WO2003030793A1 (en) * | 2001-10-12 | 2003-04-17 | Cns, Incorporated | Hydrating nasal gel and applicator |
WO2003043596A2 (en) * | 2001-11-21 | 2003-05-30 | Johnson & Johnson Consumer France S.A.S. | Compositions comprising an ethanolamine derivative and organic metal salts |
-
2005
- 2005-11-03 GB GB0522423A patent/GB2431874A/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003028691A2 (en) * | 2001-09-27 | 2003-04-10 | Johnson & Johnson Consumer France S.A.S. | Stable compositions containing ethanolamine derivatives and glucosides |
WO2003030793A1 (en) * | 2001-10-12 | 2003-04-17 | Cns, Incorporated | Hydrating nasal gel and applicator |
WO2003043596A2 (en) * | 2001-11-21 | 2003-05-30 | Johnson & Johnson Consumer France S.A.S. | Compositions comprising an ethanolamine derivative and organic metal salts |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120263694A1 (en) * | 2009-04-01 | 2012-10-18 | Susan Mary Lennox | Intimate Lubrication Kit |
CN110709070A (en) * | 2017-03-31 | 2020-01-17 | Itf制药研究责任有限公司 | Lubricating oil formulation |
EP3603627A4 (en) * | 2017-03-31 | 2021-01-06 | ITF Research Pharma, S.L.U | Lubricant formulations |
Also Published As
Publication number | Publication date |
---|---|
GB0522423D0 (en) | 2005-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kupperman et al. | Contemporary therapy of the menopausal syndrome | |
US6811549B2 (en) | Administration of therapeutic or diagnostic agents using interlabial pad | |
SA00210404B1 (en) | Administration of non-oral androgenic steroids to women | |
Cundill | Hormone therapy for trans and gender diverse patients in the general practice setting | |
MX2008009177A (en) | Method of treating atrophic vaginitis. | |
AU2014235693B2 (en) | Topical copper ion treatments in the genital-rectal areas of the body | |
JP2019081780A (en) | Lower dosage strength intranasal testosterone gel formulations, and use thereof for treating anorgasmia or hypoactive sexual desire disorder | |
JP2017520518A (en) | Devices and formulations for the local treatment of pain affecting the vulva region of the human female genital tract | |
CN105407886A (en) | Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body | |
WO1999038472A2 (en) | Topical vasodilatory gel composition and methods of use and production | |
US20020177582A1 (en) | Vaginal applicator | |
Batur et al. | Update on contraception: benefits and risks of the new formulations | |
GB2431874A (en) | Lubricant | |
Wildemeersch et al. | Assessment of menstrual blood loss in Belgian users of the frameless copper-releasing IUD with copper surface area of 200 mm2 and users of a copper-levonorgestrel-releasing intrauterine system | |
WO2013012430A1 (en) | Dhea bioadhesive controlled release gel | |
US20210220185A1 (en) | Hydrogen-delivering system for a bodily orifice | |
WO2017143119A1 (en) | Topical anorgasmia therapy | |
EP3498276B1 (en) | Ectoine and ectoine derivatives for use in vulvovaginal conditions | |
US20150272986A1 (en) | Composition for alleviating conditions associated with vaginal dryness | |
US20040072911A1 (en) | Composition for treating hemorrhoids | |
US9320744B2 (en) | DHEA bioadhesive controlled release gel | |
CN108853007B (en) | A kind of gel preparation and application thereof for treating functional uterine bleeding | |
AU2002222221B2 (en) | Topical composition and method for treating urinary stress incontinence | |
CA2498457C (en) | Composition for treating hemorrhoids | |
Ghumman | Atrophic vaginitis: diagnosis and treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
COOA | Change in applicant's name or ownership of the application |
Owner name: G.R. LANE HEALTH PRODUCTS LIMITED Free format text: FORMER APPLICANT(S): CST MEDICAL LTD |
|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |